001     241155
005     20240229154916.0
024 7 _ |a 10.1038/s43018-023-00513-2
|2 doi
024 7 _ |a pmid:36732635
|2 pmid
024 7 _ |a altmetric:142084573
|2 altmetric
037 _ _ |a DKFZ-2023-00263
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Altea-Manzano, Patricia
|0 0000-0002-7075-2051
|b 0
245 _ _ |a A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling.
260 _ _ |a London
|c 2023
|b Nature Research
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1680157298_7806
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Mar;4(3):344-364
520 _ _ |a Metabolic rewiring is often considered an adaptive pressure limiting metastasis formation; however, some nutrients available at distant organs may inherently promote metastatic growth. We find that the lung and liver are lipid-rich environments. Moreover, we observe that pre-metastatic niche formation increases palmitate availability only in the lung, whereas a high-fat diet increases it in both organs. In line with this, targeting palmitate processing inhibits breast cancer-derived lung metastasis formation. Mechanistically, breast cancer cells use palmitate to synthesize acetyl-CoA in a carnitine palmitoyltransferase 1a-dependent manner. Concomitantly, lysine acetyltransferase 2a expression is promoted by palmitate, linking the available acetyl-CoA to the acetylation of the nuclear factor-kappaB subunit p65. Deletion of lysine acetyltransferase 2a or carnitine palmitoyltransferase 1a reduces metastasis formation in lean and high-fat diet mice, and lung and liver metastases from patients with breast cancer show coexpression of both proteins. In conclusion, palmitate-rich environments foster metastases growth by increasing p65 acetylation, resulting in a pro-metastatic nuclear factor-kappaB signaling.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Doglioni, Ginevra
|0 0000-0002-9470-4476
|b 1
700 1 _ |a Liu, Yawen
|b 2
700 1 _ |a Cuadros, Alejandro M
|0 0000-0002-5900-5143
|b 3
700 1 _ |a Nolan, Emma
|b 4
700 1 _ |a Fernández-García, Juan
|0 0000-0003-3422-3627
|b 5
700 1 _ |a Wu, Qi
|b 6
700 1 _ |a Planque, Mélanie
|b 7
700 1 _ |a Laue, Kathrin Julia
|b 8
700 1 _ |a Cidre-Aranaz, Florencia
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Liu, Xiao-Zheng
|b 10
700 1 _ |a Marin-Bejar, Oskar
|0 0000-0002-6889-6566
|b 11
700 1 _ |a Van Elsen, Joke
|0 0000-0002-7349-043X
|b 12
700 1 _ |a Vermeire, Ines
|0 0000-0003-3366-7410
|b 13
700 1 _ |a Broekaert, Dorien
|0 0000-0002-9777-1607
|b 14
700 1 _ |a Demeyer, Sofie
|0 0000-0002-8193-5734
|b 15
700 1 _ |a Spotbeen, Xander
|b 16
700 1 _ |a Idkowiak, Jakub
|b 17
700 1 _ |a Montagne, Aurélie
|b 18
700 1 _ |a Demicco, Margherita
|0 0000-0002-9396-3281
|b 19
700 1 _ |a Alkan, H Furkan
|b 20
700 1 _ |a Rabas, Nick
|b 21
700 1 _ |a Riera-Domingo, Carla
|0 0000-0001-7277-234X
|b 22
700 1 _ |a Richard, François
|0 0000-0003-4353-3619
|b 23
700 1 _ |a Geukens, Tatjana
|b 24
700 1 _ |a De Schepper, Maxim
|b 25
700 1 _ |a Leduc, Sophia
|b 26
700 1 _ |a Hatse, Sigrid
|0 0000-0002-6764-2628
|b 27
700 1 _ |a Lambrechts, Yentl
|0 0000-0002-9013-8091
|b 28
700 1 _ |a Kay, Emily Jane
|b 29
700 1 _ |a Lilla, Sergio
|0 0000-0003-3142-7640
|b 30
700 1 _ |a Alekseenko, Alisa
|0 0000-0002-4269-4894
|b 31
700 1 _ |a Geldhof, Vincent
|b 32
700 1 _ |a Boeckx, Bram
|b 33
700 1 _ |a de la Calle Arregui, Celia
|0 0000-0002-4627-2963
|b 34
700 1 _ |a Floris, Giuseppe
|0 0000-0003-2391-5425
|b 35
700 1 _ |a Swinnen, Johannes V
|0 0000-0002-7720-5077
|b 36
700 1 _ |a Marine, Jean-Christophe
|b 37
700 1 _ |a Lambrechts, Diether
|0 0000-0002-3429-302X
|b 38
700 1 _ |a Pelechano, Vicent
|0 0000-0002-9415-788X
|b 39
700 1 _ |a Mazzone, Massimiliano
|0 0000-0001-8824-4015
|b 40
700 1 _ |a Zanivan, Sara
|0 0000-0002-9880-9099
|b 41
700 1 _ |a Cools, Jan
|0 0000-0001-6626-5843
|b 42
700 1 _ |a Wildiers, Hans
|0 0000-0001-8990-7837
|b 43
700 1 _ |a Baud, Véronique
|0 0000-0002-4090-718X
|b 44
700 1 _ |a Grünewald, Thomas
|0 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c
|b 45
|u dkfz
700 1 _ |a Ben-David, Uri
|0 0000-0001-7098-2378
|b 46
700 1 _ |a Desmedt, Christine
|0 0000-0002-5223-5579
|b 47
700 1 _ |a Malanchi, Ilaria
|0 0000-0003-4867-3311
|b 48
700 1 _ |a Fendt, Sarah-Maria
|0 0000-0001-6018-9296
|b 49
773 _ _ |a 10.1038/s43018-023-00513-2
|0 PERI:(DE-600)3005299-3
|n 3
|p 344-364
|t Nature cancer
|v 4
|y 2023
|x 2662-1347
909 C O |p VDB
|o oai:inrepo02.dkfz.de:241155
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 45
|6 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2022-11-08
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-08
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-08
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT CANCER : 2022
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-26
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b NAT CANCER : 2022
|d 2023-08-26
920 1 _ |0 I:(DE-He78)B410-20160331
|k B410
|l Translationale Pädiatrische Sarkomforschung
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B410-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21